
Marsha M. Tsay
Examiner (ID: 10087, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1119 |
| Issued Applications | 471 |
| Pending Applications | 134 |
| Abandoned Applications | 540 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20321351
[patent_doc_number] => 20250333439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 19/264681
[patent_app_country] => US
[patent_app_date] => 2025-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19264681
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/264681 | PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION | Jul 8, 2025 | Pending |
Array
(
[id] => 20121835
[patent_doc_number] => 20250236866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE
[patent_app_type] => utility
[patent_app_number] => 19/173652
[patent_app_country] => US
[patent_app_date] => 2025-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173652
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/173652 | EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE | Apr 7, 2025 | Pending |
Array
(
[id] => 20121836
[patent_doc_number] => 20250236867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE
[patent_app_type] => utility
[patent_app_number] => 19/173657
[patent_app_country] => US
[patent_app_date] => 2025-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173657
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/173657 | EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE | Apr 7, 2025 | Pending |
Array
(
[id] => 19512086
[patent_doc_number] => 20240343772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => Fusion protein and its preparation method for intermediate polypeptide of Semaglutide
[patent_app_type] => utility
[patent_app_number] => 18/755691
[patent_app_country] => US
[patent_app_date] => 2024-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18755691
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/755691 | Fusion protein and its preparation method for intermediate polypeptide of Semaglutide | Jun 26, 2024 | Issued |
Array
(
[id] => 19601449
[patent_doc_number] => 20240392329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES
[patent_app_type] => utility
[patent_app_number] => 18/737619
[patent_app_country] => US
[patent_app_date] => 2024-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737619
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/737619 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES | Jun 6, 2024 | Abandoned |
Array
(
[id] => 20330818
[patent_doc_number] => 12461089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Olfactory receptor involved in the perception of musk fragrance and the use thereof
[patent_app_type] => utility
[patent_app_number] => 18/406031
[patent_app_country] => US
[patent_app_date] => 2024-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 17645
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406031
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/406031 | Olfactory receptor involved in the perception of musk fragrance and the use thereof | May 29, 2024 | Issued |
Array
(
[id] => 19862606
[patent_doc_number] => 20250101392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => Enzyme Variants With Improved Ester Synthase Properties
[patent_app_type] => utility
[patent_app_number] => 18/662446
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662446 | Enzyme variants with improved ester synthase properties | May 12, 2024 | Issued |
Array
(
[id] => 19543456
[patent_doc_number] => 20240360492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => COAGULATION AND FIBRINOLYSIS ASSAYS
[patent_app_type] => utility
[patent_app_number] => 18/657130
[patent_app_country] => US
[patent_app_date] => 2024-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657130
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/657130 | COAGULATION AND FIBRINOLYSIS ASSAYS | May 6, 2024 | Pending |
Array
(
[id] => 19745975
[patent_doc_number] => 20250034540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => BOTULINUM NEUROTOXIN BIOHYBRID
[patent_app_type] => utility
[patent_app_number] => 18/615341
[patent_app_country] => US
[patent_app_date] => 2024-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18615341
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/615341 | BOTULINUM NEUROTOXIN BIOHYBRID | Mar 24, 2024 | Pending |
Array
(
[id] => 19432520
[patent_doc_number] => 20240301018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => PD-1 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/584363
[patent_app_country] => US
[patent_app_date] => 2024-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18584363
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/584363 | PD-1 homing endonuclease variants, compositions, and methods of use | Feb 21, 2024 | Issued |
Array
(
[id] => 19658830
[patent_doc_number] => 20240425895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => Cell-Free Protein Synthesis
[patent_app_type] => utility
[patent_app_number] => 18/441456
[patent_app_country] => US
[patent_app_date] => 2024-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18441456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/441456 | Cell-Free Protein Synthesis | Feb 13, 2024 | Pending |
Array
(
[id] => 19658830
[patent_doc_number] => 20240425895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => Cell-Free Protein Synthesis
[patent_app_type] => utility
[patent_app_number] => 18/441456
[patent_app_country] => US
[patent_app_date] => 2024-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18441456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/441456 | Cell-Free Protein Synthesis | Feb 13, 2024 | Pending |
Array
(
[id] => 19658830
[patent_doc_number] => 20240425895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => Cell-Free Protein Synthesis
[patent_app_type] => utility
[patent_app_number] => 18/441456
[patent_app_country] => US
[patent_app_date] => 2024-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18441456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/441456 | Cell-Free Protein Synthesis | Feb 13, 2024 | Pending |
Array
(
[id] => 19034269
[patent_doc_number] => 20240084084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => PROMOTER FOR YEAST
[patent_app_type] => utility
[patent_app_number] => 18/512485
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512485
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/512485 | PROMOTER FOR YEAST | Nov 16, 2023 | Issued |
Array
(
[id] => 19855552
[patent_doc_number] => 12258375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Mutant lysenin pores
[patent_app_type] => utility
[patent_app_number] => 18/504590
[patent_app_country] => US
[patent_app_date] => 2023-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28377
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18504590
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/504590 | Mutant lysenin pores | Nov 7, 2023 | Issued |
Array
(
[id] => 19281553
[patent_doc_number] => 20240218027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/503341
[patent_app_country] => US
[patent_app_date] => 2023-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18503341
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/503341 | NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | Nov 6, 2023 | Abandoned |
Array
(
[id] => 19431067
[patent_doc_number] => 20240299565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => TOXIN-DERIVED DELIVERY CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 18/502473
[patent_app_country] => US
[patent_app_date] => 2023-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18502473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/502473 | TOXIN-DERIVED DELIVERY CONSTRUCTS | Nov 5, 2023 | Abandoned |
Array
(
[id] => 18971927
[patent_doc_number] => 20240052019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => SINGLE ALPHA CHAIN COLLAGENS
[patent_app_type] => utility
[patent_app_number] => 18/384018
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18384018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/384018 | SINGLE ALPHA CHAIN COLLAGENS | Oct 25, 2023 | Pending |
Array
(
[id] => 18971927
[patent_doc_number] => 20240052019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => SINGLE ALPHA CHAIN COLLAGENS
[patent_app_type] => utility
[patent_app_number] => 18/384018
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18384018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/384018 | SINGLE ALPHA CHAIN COLLAGENS | Oct 25, 2023 | Pending |
Array
(
[id] => 18955523
[patent_doc_number] => 20240043850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => COMPOSITIONS AND METHODS FOR TYPE III POLYKETIDE PRODUCTION IN OLEAGINOUS YEAST SPECIES
[patent_app_type] => utility
[patent_app_number] => 18/486403
[patent_app_country] => US
[patent_app_date] => 2023-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18486403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/486403 | COMPOSITIONS AND METHODS FOR TYPE III POLYKETIDE PRODUCTION IN OLEAGINOUS YEAST SPECIES | Oct 12, 2023 | Abandoned |